Summary
Overview
Work History
Education
Skills
Accomplishments
Selectedscientificpublications
Timeline
Generic
Abhik Datta

Abhik Datta

BioPharmaceutical Leader
Bangalore,KA

Summary

Strategic and results-driven leader with extensive expertise in biotechnology and biopharma industries. Proven track record in CMC and life cycle management of biologics. Adept at leading cross-functional teams, managing global operations, driving compliance, and fostering innovation. Skilled in stakeholder engagement, risk management, and delivering sustainable business outcomes.

Overview

17
17
years of professional experience
7
7
years of post-secondary education

Work History

Head of Operations - Biology (Deputy General Manager)

Syngene Amgen R & D Center, Syngene International Ltd
08.2020 - Current
  • Lead a team of 65+ FTEs, ensuring operational excellence, resource optimization, and adherence to EHSS and quality compliance
  • Oversee P&L management, business continuity planning, and risk mitigation strategies
  • Implement Six Sigma Black Belt initiatives to enhance process efficiency
  • Improved overall productivity with the introduction of innovative process improvement initiatives.
  • Launched staff engagement, gender diversity and cultural programs in addition to robust reporting tool that increased operational quality.
  • Implemented new systems for better data management, leading to improved decision-making processes.

Vice President – R&D Operations

Pandorum Technologies
10.2019 - 07.2020
  • Directed R&D operations, fostering a collaborative environment for innovation
  • Implemented cost optimization strategies, enhancing operational efficiency

Vice President – R&D

Stelis Bio-Pharma
05.2016 - 12.2018
  • Led early-stage development of Kauliv (osteoporosis biosimilar), securing EMA authorization
  • Managed strategic analysis and operating budgets for R&D initiatives

Head - R&D

Merck KGaA
05.2010 - 05.2016
  • Directed CMC development activities, achieving significant advancements in biopharma services
  • Recipient of Merck KGaA Emerging Talent Recognition for exceptional contributions

Functional Head

Avesthagen Ltd.
03.2008 - 04.2010
  • Led cross-functional teams, driving innovation and operational excellence in biologics development

Education

MBA -

United Business Institute (UBI)
Europe
01.2011 - 12.2012

Ph.D. -

Indian Institute of Technology (IIT)
Kharagpur, India
01.1997 - 09.2001

Skills

Leadership of High Performing Teams

Accomplishments

  • 01/24, Six Sigma Black Belt, American Society for Quality (ASQ)
  • 01/22, Syngene CEO Business Achievement Award
  • 01/22, European Medical Agency (EMA) Authorization for osteoporosis biosimilar, KaulivTM (Lead team at Stelis Biopharma for development of KaulivTM)
  • 01/12, Merck KGaA Emerging Talent Recognition

Selectedscientificpublications

  • Proc Natl Acad Sci (PNAS) USA, 09/10, 107, 38, 16619-16624
  • Oncogene, 02/08, 27, 8, 1135-1141
  • J. Biol. Chem., 05/07, 282, 19, 14608-14815
  • J. Biol. Chem., 08/06, 281, 33, 23414-23424
  • Blood, 09/06, 108, 3, 1021-1029
  • Blood, 09/04, 104, 8, 2523-2531

Timeline

Head of Operations - Biology (Deputy General Manager)

Syngene Amgen R & D Center, Syngene International Ltd
08.2020 - Current

Vice President – R&D Operations

Pandorum Technologies
10.2019 - 07.2020

Vice President – R&D

Stelis Bio-Pharma
05.2016 - 12.2018

MBA -

United Business Institute (UBI)
01.2011 - 12.2012

Head - R&D

Merck KGaA
05.2010 - 05.2016

Functional Head

Avesthagen Ltd.
03.2008 - 04.2010

Ph.D. -

Indian Institute of Technology (IIT)
01.1997 - 09.2001
Abhik DattaBioPharmaceutical Leader